Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial-Reference-Cited by-同舟云学术

Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial

Published:2012-11 Issue:9855 Volume:380 Page:1749-1758
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Lopes Renato D,Al-Khatib Sana M,Wallentin Lars,Yang Hongqiu,Ansell Jack,Bahit M Cecilia,De Caterina Raffaele,Dorian Paul,Easton J Donald,Erol Cetin,Ezekowitz Justin A,Gersh Bernard J,Granger Christopher B,Hohnloser Stefan H,Horowitz John,Hylek Elaine M,McMurray John JV,Mohan Puneet,Vinereanu Dragos,Alexander John H

Publisher

Elsevier BV

Subject

General Medicine

Reference37 articles.

1. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation;Hart;Ann Intern Med,2007

2. 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

3. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC);Camm;Eur Heart J,2010

4. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter;Cairns;Can J Cardiol,2011

5. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009

Cited by 171 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apixaban, edoxaban and rivaroxaban but not dabigatran are associated with higher mortality compared to vitamin‐K antagonists: A retrospective German claims data analysis;Journal of Internal Medicine;2024-09-02

2. Apixaban vs rivaroxaban in patients with atrial fibrillation at high or low bleeding risk: A population-based cohort study;Heart Rhythm;2024-08

3. Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation;Cardiology Discovery;2024-05-29

4. Chinese guidelines for the diagnosis and management of atrial fibrillation;Pacing and Clinical Electrophysiology;2024-04-30

5. Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial;Journal of the American Heart Association;2024-04-02